Product Information
DAPAGLIFLOZIN 5 MG TABLET is a generic product labeled by Prasco Laboratories, priced at $0.1845 per EA under NDC 66993045630. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
5 mg/1
Manufacturer
Prasco LaboratoriesNDC
66993045630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/3/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA202293On Market Since
1/3/2024
Pharmacological Classes
Price Statistics
The NADAC for DAPAGLIFLOZIN 5 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 98.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1845 per EA |
|---|---|
| All-time high | $11.7436 (Oct 16, 2024) |
| All-time low | $0.1845 (Jun 3, 2026) |
| 52-week high | $11.5971 |
| 52-week low | $0.1845 |
| Median price | $11.4574 |
| Average price | $11.0603 |
| Largest weekly change | -98.4% (Jun 3, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPAGLIFLOZIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DAPAGLIFLOZIN 5 MG TABLET, manufactured by Prasco Laboratories, is $0.1845 per EA (NDC 66993045630), effective Jun 24, 2026.
How has the price of DAPAGLIFLOZIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DAPAGLIFLOZIN 5 MG TABLET has declined 98.4%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DAPAGLIFLOZIN 5 MG TABLET?
Since Apr 17, 2024, the NADAC for DAPAGLIFLOZIN 5 MG TABLET has ranged from a low of $0.1845 (Jun 3, 2026) to a high of $11.7436 (Oct 16, 2024), with a median of $11.4574 per EA.
Are there cheaper alternatives to DAPAGLIFLOZIN 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DAPAGLIFLOZIN 5 MG TABLET, but none are currently priced below it.
Who manufactures DAPAGLIFLOZIN 5 MG TABLET?
DAPAGLIFLOZIN 5 MG TABLET (NDC 66993045630) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.